Gharib E, Robichaud G
Int J Mol Sci. 2024; 25(17).
PMID: 39273409
PMC: 11395697.
DOI: 10.3390/ijms25179463.
Yu P, Luo J, Song H, Qian T, He X, Fang J
Int J Med Sci. 2022; 19(4):740-752.
PMID: 35582415
PMC: 9108398.
DOI: 10.7150/ijms.69807.
Touboul R, Baritaki S, Zaravinos A, Bonavida B
Cancers (Basel). 2021; 13(24).
PMID: 34944867
PMC: 8699197.
DOI: 10.3390/cancers13246247.
Binobaid L, Masternak M
Rep Pract Oncol Radiother. 2020; 25(4):556-561.
PMID: 32494228
PMC: 7256061.
DOI: 10.1016/j.rpor.2020.04.010.
Obasaju P, Shahab S, Dunn E, Rhee D, Jiang L, Dome J
Cold Spring Harb Mol Case Stud. 2020; 6(2).
PMID: 32238401
PMC: 7133746.
DOI: 10.1101/mcs.a004820.
Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.
Parker M, Nikonova A, Sun D, Golemis E
Cell Signal. 2019; 67:109497.
PMID: 31830556
PMC: 6957738.
DOI: 10.1016/j.cellsig.2019.109497.
Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation.
Virzi A, Gentile A, Benvenuti S, Comoglio P
Proc Natl Acad Sci U S A. 2018; 115(40):10058-10063.
PMID: 30224486
PMC: 6176587.
DOI: 10.1073/pnas.1721147115.
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways.
Wee P, Wang Z
Cancers (Basel). 2017; 9(5).
PMID: 28513565
PMC: 5447962.
DOI: 10.3390/cancers9050052.
K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth.
Dalpa E, Gourvas V, Soulitzis N, Spandidos D
Med Oncol. 2016; 34(1):6.
PMID: 27943100
DOI: 10.1007/s12032-016-0862-5.
Bipartite Role of Heat Shock Protein 90 (Hsp90) Keeps CRAF Kinase Poised for Activation.
Mitra S, Ghosh B, Gayen N, Roy J, Mandal A
J Biol Chem. 2016; 291(47):24579-24593.
PMID: 27703006
PMC: 5114410.
DOI: 10.1074/jbc.M116.746420.
β-catenin signaling is required for RAS-driven thyroid cancer through PI3K activation.
Sastre-Perona A, Riesco-Eizaguirre G, Zaballos M, Santisteban P
Oncotarget. 2016; 7(31):49435-49449.
PMID: 27384483
PMC: 5226519.
DOI: 10.18632/oncotarget.10356.
Lack of BRAFV600E mutation in stage I and II of colorectal cancer.
Molaei M, Kishani Farahani R, Maftouh M, Taleghani M, Vahdatinia M, Khatami F
Gastroenterol Hepatol Bed Bench. 2016; 9(2):94-9.
PMID: 27099668
PMC: 4833847.
Nanoformulated Mutant SurR9-C84A: a Possible Key for Alzheimer's and its Associated Inflammation.
Sriramoju B, Kanwar R, Kanwar J
Pharm Res. 2015; 32(8):2787-97.
PMID: 25773719
DOI: 10.1007/s11095-015-1664-8.
Ras Activity Oscillates in the Mouse Suprachiasmatic Nucleus and Modulates Circadian Clock Dynamics.
Serchov T, Jilg A, Wolf C, Radtke I, Stehle J, Heumann R
Mol Neurobiol. 2015; 53(3):1843-1855.
PMID: 25762011
DOI: 10.1007/s12035-015-9135-0.
IL-4 type 1 receptor signaling up-regulates KCNN4 expression, and increases the KCa3.1 current and its contribution to migration of alternative-activated microglia.
Ferreira R, Lively S, Schlichter L
Front Cell Neurosci. 2014; 8:183.
PMID: 25071444
PMC: 4077126.
DOI: 10.3389/fncel.2014.00183.
Inflammatory response of monocytes to ambient particles varies by highway proximity.
Wu W, Muller R, Berhane K, Fruin S, Liu F, Jaspers I
Am J Respir Cell Mol Biol. 2014; 51(6):802-9.
PMID: 24895888
PMC: 4291543.
DOI: 10.1165/rcmb.2013-0265OC.
RKIP and 14-3-3ε exert an opposite effect on human gastric cancer cells SGC7901 by regulating the ERK/MAPK pathway differently.
Yan L, Gu H, Li J, Xu M, Liu T, Shen Y
Dig Dis Sci. 2012; 58(2):389-96.
PMID: 22899242
DOI: 10.1007/s10620-012-2341-y.
Downregulation of galectin-3 by EGF mediates the apoptosis of HepG2 cells.
Hu Z, Jiang X, Xu Y, Lu N, Wang W, Luo J
Mol Cell Biochem. 2012; 369(1-2):157-65.
PMID: 22761016
DOI: 10.1007/s11010-012-1378-8.
MAP Kinases and Prostate Cancer.
Rodriguez-Berriguete G, Fraile B, Martinez-Onsurbe P, Olmedilla G, Paniagua R, Royuela M
J Signal Transduct. 2011; 2012:169170.
PMID: 22046506
PMC: 3199183.
DOI: 10.1155/2012/169170.
ERK/MAPK is essential for endogenous neuroprotection in SCN2.2 cells.
Karmarkar S, Bottum K, Krager S, Tischkau S
PLoS One. 2011; 6(8):e23493.
PMID: 21858143
PMC: 3157406.
DOI: 10.1371/journal.pone.0023493.